Abstract:BACKGROUND: Liver transplantation is an effective treatment for end-stage liver disease, but a huge gap remains between the number of people who need a liver transplant and the number of organs available. In order to maximize donor organ access for adult and pediatric recipients, novel surgical and liver replacement procedures have evolved. Newer surgical techniques include split cadaveric liver transplantation and living donor liver transplantation (LDLT). With marginal and abnormal donor livers, despite tremendous advances in surgical technology, individual surgical procedure can not be completely brought into play unless effective measurements and basal studies are undertaken.DATA SOURCES: A literature search of MEDLINE and the Web of Science database using "liver transplantation" and "expanding donor pool" was conducted and research articles were reviewed.RESULTS: Therapies directed toward scavenging O2-, inhibiting nicotinamide adenine dinucleotide phosphate oxidase, and/or immuno-neutralizing tumor necrosis factor-alpha may prove useful in limiting the liver injury induced by surgical procedures such as split liver transplantation or LDLT. Improved donor organ perfusion and preservation methods, modulation of inflammatory cytokines, energy status enhancement, microcirculation amelioration, and antioxidant usage can improve non-heart beating donor liver transplantation. Effective measures have been taken to improve the local conditions of donor cells with steatosis, including usage of fat-derived hormone and inflammatory mediators, ischemic preconditioning, depletion of Kupffer cells, and cytokine antibody and gene therapy. Double-filtration plasmapheresis can effectively reduce HCV viremia and prevent HCV recurrence in patient with high HCV RNA levels after LDLT.CONCLUSIONS: Shortage of grafts and poor function of marginal and abnormal donor grafts put many patients at risk of death in waiting for liver transplantation. Advances in surgical technology, combined with improvement and breakthroughs in basic studies hold a promise in expanding the liver donor pool.

Recent Controversies in Liver Transplantation

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Reply to ‘how to Select Eligible Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus for Deceased Donor Liver Transplantation?’

Liver Transplantation in China: Problems and Their Solutions.

Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies

Recent trends and new developments in liver transplantation

Split liver transplantation: Current status and future trend

Four Decades of Clinical Liver Transplantation Research: Results of a Comprehensive Bibliometric Analysis

An Overview of Liver Transplantation: Current Status, Recent Techniques, and Challenges-Perspectives From a Center in China.

The future of Liver Transplantation

Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future

Changing landscape of liver transplant in the United States- time for a new innovative way to define and utilize the "non-standard liver allograft"-a proposal

Recent Advances in Liver Transplantation for Hepatocellular Carcinoma

Role of Basic Studies in Expanding the Donor Pool for Liver Transplantation

Challenges and Opportunities of Liver Xenotransplantation

Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis

Current Status of Living Donor Liver Transplantation: Impact, Advantages, and Challenges

New Scenarios in Liver Transplantation for Hepatocellular Carcinoma

Ethical Issues in Living Related Liver Transplantation

Assessing Donor Liver Quality and Restoring Graft Function in the Era of Extended Criteria Donors.